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Abstracts / Osteoarthritis and Cartilage 21 (2013) S63–S312S136THA, and to account for lack of experience by performing a sensitivity
analysis excluding these surgeons.
Methods: We deﬁned a cohort of patients who received their ﬁrst
primary elective THA between 2002-2009 utilizing health administra-
tive databases from Ontario, Canada. We excluded those who had
received a primary or revision arthroplasty of the hip or knee prior to
April 1, 2002, and those whose ﬁrst procedure was non-elective (e.g. for
cancer, fracture, or external cause of injury), or if the patient had
a diagnosis of an inﬂammatory arthritis. Surgeon volume was deter-
mined by pooling the number of primary and revision THAs performed
by the primary surgeon in the 365d prior to the surgery and catego-
rizing by quartiles (lowest: 30; 2nd: 31-50; 3rd: 51-75; 4th: >75 cases).
Generalized estimating equations were used to determine the rela-
tionship between volume quartile and the occurrence of speciﬁc
complications (within 90d: DVT/PE, AMI; within 2y: dislocation,
infection and revision) after controlling for potential confounders
(income quintile, rurality, prior intra-articular injection, and hospital
volume), and accounting for clustering by surgeons. We repeated our
analysis after excluding patients of surgeons who had graduated from
medical school less than years before performing the THA. A propensity
score for treatment by the lowest quartile, versus any of the other
quartiles, was developed and used as a balancing score. The number
needed to harm (NNH) for each complication was then determined.
Results: Between April 1, 2002 and March 31, 2009, there were 37,881
THA recipients (lowest volume quartile: 7,267 patients; 2nd: 9,307
patients; 3rd: 9,566 patients; highest volume quartile: 11,741 patients).
Relative to the highest surgeon volume quartile of hip replacements,
THA recipients in the lowest quartile were more likely to be female
(lowest: 57.1%, highest: 53.2%, p<0.001), older (lowest: mean age 68.1y,
highest: 63.6y, p<0.001), and reside in a rural area (p<0.001).
Controlling for these differences, and for clustering among surgeons,
THA recipients treated by surgeons in the lowest volume quartile were
at increased risk of dislocation (adjusted OR 1.60, 95%CI 1.26, 2.05,
p<0.0001) and revision within 2y of THA (adjusted OR 1.59, 95%CI 1.25,
2.02, p¼0.0002) relative to all other THA recipients. This increased risk
persisted after excluding surgeons with less experience (dislocation:
adjusted OR 1.63, 95%CI 1.24, 2.14, p¼0.0004; revision: adjusted OR
1.49, 95%CI 1.11, 1.98, p¼0.0071). Propensity score matching matched
6,827 patients who received their THA from a surgeon in the lowest
volume quartile (94% of potential cases) with 15,840 patients who
received their THA from a surgeon in any of the other volume quartile
(52% of potential controls). The number needed to harm for THA
recipients who received their THA from a surgeon in the lowest volume
quartile was 149 patients for dislocation, and 167 patients for revision
within 2years.
Conclusions: Patients who receive their THA by surgeons in the lowest
volume quartile (deﬁned here as 30 or fewer cases annually) had
increased risk for early revision and dislocation. This increased risk
persists after accounting for lack of surgeon experience. To our
knowledge, this is the ﬁrst study to demonstrate this relationship in
Canada, and to quantify the added risk.248
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Purpose: Osteoarthritis (OA) is a leading cause of activity limitations
among older adults. The knee OA population is heterogeneous and is
likely to consist of subgroups with distinct trajectories of activity limi-
tations. The aim of the present study was to identify homogeneous
subgroups with distinct trajectories of activity limitations in patients
with early symptomatic knee OA, and to describe characteristics of
these subgroups.
Methods: Follow-up data over a period of ﬁve years of 697 participants
with early symptomatic knee OA from the Cohort Hip and Cohort Knee
(CHECK) were used. Activity limitations were measured yearly (six
measurements over time) with the Western Ontario and McMasterUniversities Osteoarthritis Index. Latent class growth analyses identi-
ﬁed homogeneous subgroups with distinct trajectories of activity
limitations. Multivariable regression analyses examined differences in
characteristics between the subgroups.
Results: Three subgroups were identiﬁed. Participants in Subgroup 1
(‘good outcome’; n¼330) developed or displayed slight activity limita-
tions over time. Participants in Subgroup2 (‘moderate outcome’; n¼257)
developed or displayed moderate activity limitations over time. Partic-
ipants in subgroup 3 (‘poor outcome’; n¼110) developed or displayed
severe activity limitations over time. Compared to the ‘good outcome’
subgroup, the ‘moderate outcome’ and ‘poor outcome’ subgroups were
characterized by: younger age, higher body-mass index, greater pain,
bony tenderness, reduced knee ﬂexion, hip pain, osteophytosis, 3
comorbidities, lower vitality, or avoidance of activities.
Conclusions: Based on the 5-year course of activity limitations exam-
ined in our study, we identiﬁed homogeneous subgroups of knee OA
patients with good, moderate or poor outcome. Characteristics of these
subgroups were consistent with existing knowledge on prognostic
factors regarding activity limitations, which supports the validity of this
classiﬁcation. Identiﬁcation of homogeneous subgroups may contribute
to the development of tailored preventive interventions in knee OA
patients.249
DO HIGH MOLECULAR WEIGHT ADIPONECTIN LEVELS ASSOCIATE
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Purpose: Adipose tissue can secrete many different soluble factors
(adipokines) inﬂuencing whole body metabolism. Some of these adi-
pokines, such as adiponectin, have been shown to inﬂuence radio-
graphic progression in osteoarthritis (OA) and rheumatoid arthritis
(RA). In RA patients, total adiponectin (totAPN) levels in serum associate
positively with radiographic progression, which suggestes an adverse
effect on disease. Intruiguingly, in patients with hand OA, high totAPN
levels in serum associated with a decreased relative risk for radio-
graphic progression, suggesting a beniﬁcial effect on disease.
Adiponectin is a pleiotropic adipokine, which consists of several iso-
forms. Of these isoforms, high molecular weight adiponectin
(hmwAPN) has been described as one of the most biologically active
and its effect on radiographic progression in RA and hand OA is
unknown. Therefore, we explored the possibility that the association
between totAPN and disease progression is primarily mediated by the
hmwAPN isoform.
Methods: Concentrations of hmwAPN and totAPN were determined in
baseline plasma of 324 RA patients from the Early Arthritis Cohort
(EAC) and in baseline sera of 164 hand OA patients from the Genetics
Arthrosis and Progression (GARP) study. The association between
levels of hmwAPN and totAPN with radiographic progression were
determined using a multivariate normal regression model (EAC cohort)
or by generalized estimated equations (GARP cohort). Adjustments
were made for age, gender, treatment strategy and Body Mass Index
(BMI).
Results: In RA patients totAPN associated positively with radiographic
progression (Sharp van der Heijde scores) (association estimate 3.65,
p ¼ 0.002), whereas in patients with hand OA, totAPN associated
negatively with radiographic progression (joint space narrowing
(JSN)) (Odds 0.24/ Odds 0.21, p ¼ 0.002/ p ¼ 0.002 two highest tertiles
compared to the lowest tertile). HmwAPN on the other hand, did not
associate signiﬁcantly with radiographic progression in patients with
hand OA or RA, although in patients with RA we did observe a trend
towards a positive association (association estimate 1.53 p ¼ 0.07)
upon correcting for age, gender and treatment strategy. This trend
was lost after further adjustment for BMI. Similar results were ob-
tained when joint space narrowing (JSN) was used as outcome
measurement.
Conclusions: Our data further substantiate the connection between
APN-levels and radiographic progression in rheumatic disease and
indicate that the differential effects associated between totAPN and
radiographic progression in either in RA and hand OA is not mediated
by (a selective effect of) hmwAPN.
